Open Beta
TREN
MetriLume
TREN

US marketsPROF

SEC-sourced researchBeta

PROF

Profound Medical Corp.

Company comparison ↗

Data passport

CIK
0001628808
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 10,680,000.0000 USD; December 2025: 16,098,000.0000 USD16.1M USD0 USD0December 2024December 2025
PROF · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202410,680,000.0000Mar 5, 2026
December 202516,098,000.0000Mar 5, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202516,098,000.0000-42,570,000.0000-38,207,000.000077,475,000.000011,041,000.0000Mar 5, 2026
December 202410,680,000.0000-27,816,000.0000-23,453,000.000070,234,000.00009,812,000.0000Mar 5, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$16.1MDecember 2025Mar 5, 202610-K
Previous period revenueRevenues$10.68MDecember 2024Mar 5, 202610-K
Net incomeNetIncomeLoss-$42.57MDecember 2025Mar 5, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$38.21MDecember 2025Mar 5, 202610-K
Total assetsAssets$77.48MDecember 2025Mar 5, 202610-K
Total liabilitiesLiabilities$11.04MDecember 2025Mar 5, 202610-K

New filings

Explore methodology ↗